William Reed Little files SEC Form 4 disclosures for Orchestra BioMed Holdings, Inc.. They have made 1 open-market trade across 1 company since 2024, most recently 2024-05-30.
CIK 0001980978
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $28K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OBIO | 307,859 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2024-06-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OBIO | BUY | 2024-05-30 | 2024-06-03 | $7.00 | $28K | +8.9% | +5.4% | -12.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.